Showing results (11-20 of 306) with videos related to
Sort By:
Pageof 31
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2W Wick, C Grimmel, C Wild-Bode, et al.Cancer Research|April 6, 2001
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxisW Roth, S Isenmann, M Nakamura, et al.Rivista Di Neurologia|May 1, 1987
Molecular approaches toward a therapy for multiple sclerosisL SteinmanProceedings of the National Academy of Sciences of the United States of America|March 19, 1996
A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantryL SteinmanCurrent Opinion in Immunology|September 7, 2001
Immunotherapy of multiple sclerosis: the end of the beginningL SteinmanJournal of Internal Medicine|May 4, 2010
Inverse vaccination, the opposite of Jenner's concept, for therapy of autoimmunityL SteinmanMolecular Biology & Medicine|August 1, 1990
Development of antigen-specific therapies for autoimmune diseaseL SteinmanRevue Neurologique|September 7, 2014
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the futureL SteinmanJournal of Clinical Immunology|November 1, 1990
The use of monoclonal antibodies for treatment of autoimmune diseaseL SteinmanDer Nervenarzt|July 30, 2010
[Neuroradiological response criteria for malignant gliomas]M Bendszus, M PlattenPageof 31